1. Birth and maturation of cardio-oncology;Bhatt;J Am Coll Cardiol CardioOnc,2019
2. The association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcomes in anthracycline-treated patients with cancer;Abdel-Qadir;J Am Coll Cardiol CardioOnc,2023
3. Sodium-glucose co-transporter-2 inhibitors and cardiac outcomes among patients treated with anthracyclines;Gongora;J Am Coll Cardiol HF,2022
4. SGLT2 inhibitor use and risk of clinical events in patients with cancer therapy-related cardiac dysfunction;Avula;J Am Coll Cardiol HF,2024
5. DECLARE–TIMI 58 Investigators. Dapagliflozin and cardiovascular outcomes in type 2 diabetes;Wiviott;N Engl J Med,2019